The transcription factors GATA4 and GATA6 are expressed in the embryonic and postnatal gonads and implicated as regulators of gonadal functions including steroidogenesis [1, 2] . The broad spatiotemporal expression and potentially overlapping functions of GATA factors complicate the task of defining all their roles. A role in embryonic development for both factors was indicated by early studies with genetically engineered mice lacking either Gata4 or Gata6, where homozygous deletion of either gene resulted in embryonic lethality. Gata4-null mice die between Embryonic Day 8.5 (E8.5) and E10.5 with defects in ventral morphogenesis and cardiac development [3] , and Gata6-null mice die between E6.5 and E7.5 with defects in endodermal differentiation [4] . The early studies with Gata-null mice revealed little about the role of GATA4 or GATA6 in gonadal development and nothing about postnatal roles for these factors. Forced overexpression of GATA4 and GATA6 in cultured cells indicated that some gonadal gene promoters, such as that for Star and CYP19a1, could be driven efficiently by either factor [2] . In addition, RNAi-mediated depletion of GATA4, GATA6, and their combination in cultured ovarian granulosa cells revealed these GATA factors have both common and unique gene targets, with combined GATA4 plus GATA6 depletion affecting a greater number of genes than with reduction of either factor alone [5] . Yet it was not clear if the data from cell culture studies actually translated to the intact gonad or were relevant to developmental changes that occur as germ cells mature, such as during follicle maturation in the ovary, and thus more refined gene-targeting animal studies were needed.
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Since the original creation of the Gata4-and Gata6-null mice, several additional genetic approaches have been utilized to study mainly GATA4 in the developing or postnatal gonad in mice. These genetic approaches have included analyses of heterozygous mice, use of inducible Cre vectors with floxed Gata4 or Gata6 genes, Amhr2Cre targeting Gata deletions to ovarian somatic cells, and knock-in studies disrupting the interaction of GATA4 with cofactor FOG2 (recently reviewed in [6] ). Each animal model had its limitations, but each provided a piece of the puzzle regarding the role of GATA4 in gonadal development and function. GATA4 was found to be required for formation of the genital ridge of both sexes [7] . For the ovary, the common finding in most of these studies was that depletion of GATA4 results in abnormal responses to exogenous gonadotropins and impaired fertility in adults. Fewer studies addressed GATA6 function in the ovary. Only recently have the combined functions of GATA4 and GATA6 in ovarian follicular development and function been investigated using Cre vectors targeting ovarian somatic cells.
Combined requirement for GATA4 and GATA6 in postnatal follicle maturation was confirmed in a recent study by Bennett et al. [8] , who examined the individual and combined effects of GATA4 and GATA6 depletion in ovarian granulosa cells utilizing floxed Gata4 and Gata6 genes and Cre expression driven by the aromatase promoter (Cyp19Cre). Cyp19Cre is expressed in granulosa cells of all antral follicles, with low or no expression in early follicles (primordial and primary), and no Cyp19Cre-mediated recombination is observed before Postnatal Day 10 [9] . Cyp19Cre-mediated depletion of GATA4 in granulosa cells resulted in a 75% decrease in litter size, whereas GATA6 depletion had no effect; however, the combined depletion of GATA4 and GATA6 resulted in complete infertility accompanied by the absence of large preovulatory follicles and corpora lutea [8] . Moreover, combined knockdown of GATA4 and GATA6 also resulted in elevated serum FSH and LH and decreased estradiol in proestrous animals. In sum, combined depletion of GATA4 and GATA6 in the postnatal mouse starting in the peripubertal period demonstrated that there is partial compensation of GATA4 loss by GATA6 in the granulosa cells of the follicle, and that loss of both factors impedes advanced follicular development and ovulation. As exciting as these findings were, the animal model did not allow the evaluation of GATA4 and GATA6 during fetal development or the early postnatal period.
In a recent issue of Biology of Reproduction, Padua et al. [10] investigated the combined roles of GATA4 and GATA6 in fetal and early postnatal ovarian development in mice. The authors utilized Sf1Cre to create targeted Gata4/6 gene deletions within the somatic cells of the developing gonad. Sf1Cre expresses in the embryonic gonad somatic cells, adrenals, pituitary, and hypothalamus from midgestation onward [11] ; nonetheless, the extragonadal expression of Sf1Cre is not expected to impact early ovarian development. Padua et al. [10] showed that combined GATA4 and GATA6 reduction in the gonad initiated by Sf1Cre was robust by E13.5. Embryonic ovaries were evaluated at E13.5, E15.5, and E18.5 and Postnatal Days 4, 6, and 9, as animals survive only 2 wk postnatally as they lack adrenals. In the fetus, combined loss of GATA4 and GATA6 decreased the expression of genes mediating the ovarian development pathway, including Fst and Irx3, and pregranulosa and granulosa cell markers, SPPR2 and FOXL2, respectively. Normally follicle assembly in newborn mice occurs in the first few days of life, with primordial follicles forming within 2-3 days after birth [12] . In Gata4/Gata6 conditional double-mutant mice, a reduction in somatic cell proliferation was observed in all postnatal ovaries and an increase in apoptosis was measured at Postnatal Day 6, which coincided with smaller ovaries. At Day 4, the wild-type ovary exhibited the expected primordial, primary, and multilayered preantral follicles. In contrast, the ovaries of animals with combined GATA4 and GATA6 depletion exhibited only primordial follicles, and many germ cells remained in clusters and had not recruited the pregranulosa somatic cells to form individual follicles. Another feature of the mutant ovary was that demarcation between the cortex and medullary regions was absent, consistent with a loss of follicle assembly and development. Remarkably, combined GATA4/6 depletion led to the loss of most oocytes in the postnatal ovary by Day 9. Sf1Cre-mediated deletion of Gata4 alone showed a severe but incomplete block in follicular development, with few follicles reaching the antral stage [13] , and similar deletion of Gata6 exhibited normal ovarian structure and function [10] , indicating that GATA4 can compensate for GATA6 depletion for much of early ovarian development. The data strongly argue that both GATA4 and GATA6 play a cooperative role in early ovarian development.
Collectively, these recent studies show that the concerted efforts of GATA4 and GATA6 contribute to ovarian development during the embryonic stage (at E13.5 and beyond), postnatal follicle assembly, and likely follicular maintenance, as well as maturation of the follicles to the preovulatory stage. An open question that remains for the ovary is ''What roles do these GATA factors play in the corpus luteum?'' where GATA6 expression typically dominates. The answer awaits an appropriate conditional mutant mouse model that can maintain normal GATA expression through ovulation and deplete it in the new corpus luteum.
